Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C, Krueger, G G, de Vlam, K, Birbara, C, Beutler, A, Guzzo, C, Zhou, B, Dooley, L T, Kavanaugh, A
Published in Annals of the rheumatic diseases (01.08.2005)
Published in Annals of the rheumatic diseases (01.08.2005)
Get full text
Journal Article
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
Mease, P J, Ory, P, Sharp, J T, Ritchlin, C T, Van den Bosch, F, Wellborne, F, Birbara, C, Thomson, G T D, Perdok, R J, Medich, J, Wong, R L, Gladman, D D
Published in Annals of the rheumatic diseases (01.05.2009)
Published in Annals of the rheumatic diseases (01.05.2009)
Get full text
Journal Article
Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
Schnitzer, T.J, Lane, N.E, Birbara, C, Smith, M.D, Simpson, S.L, Brown, M.T
Published in Osteoarthritis and cartilage (01.06.2011)
Published in Osteoarthritis and cartilage (01.06.2011)
Get full text
Journal Article
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
Kavanaugh, A, Krueger, G G, Beutler, A, Guzzo, C, Zhou, B, Dooley, L T, Mease, P J, Gladman, D D, de Vlam, K, Geusens, P P, Birbara, C, Halter, D G, Antoni, C
Published in Annals of the rheumatic diseases (01.04.2007)
Published in Annals of the rheumatic diseases (01.04.2007)
Get full text
Journal Article
THU0416 Disease Activity and Safety During Long-Term (104-Week) Treatment with Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (Palace 3)
Edwards, C., Blanco, F., Crowley, J., Hu, C., Shah, K., Birbara, C.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials
Gladman, D., Kavanaugh, A., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Cutolo, M., Schett, G., Lespessailles, E., McIlraith, M., Hu, C., Edwards, C., Birbara, C., Mease, P.
Published in Annals of the rheumatic diseases (01.06.2015)
Published in Annals of the rheumatic diseases (01.06.2015)
Get full text
Journal Article
SAT0280 Efficacy of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis, Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
Birbara, C., Blanco, F. J., Crowley, J. J., Hu, C., Stevens, R., Edwards, C. J.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
AB0455 Disease duration, but not rheumatoid factor status, impacts clinical response in adalimumab-treated rheumatoid arthritis patients with an inadequate response to standard dmard therapy: Subgroup analysis of the DE020 continuation trial
Furst, D.E., Weinblatt, M.E., Kavanaugh, A., Birbara, C., Kupper, H., Obermeyer, K., Faccin, F.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
Birbara, C., Blanco, F. J., Crowley, J. J., Hu, C., Stevens, R., Edwards, C. J.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
AB0758 Change in Weight from Baseline during the Palace Clinical Trial Program with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Mease, P., Gladman, D., Kavanaugh, A., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Schett, G., Shah, K., Hu, C., Stevens, R., Edwards, C., Birbara, C.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials
Mease, P.J., Kavanaugh, A., Gladman, D., Adebajo, A.O., Gomez-Reino, J.J., Wollenhaupt, J., Cutolo, M., Schett, G., Lespessailles, E., Shah, K., Hu, C., Stevens, R., Edwards, C., Birbara, C.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
AB0746 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Schett, G., Mease, P., Gladman, D., Kavanaugh, A., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Cutolo, M., Lespessailles, E., Hu, C., Stevens, R., Edwards, C., Birbara, C.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
Kavanaugh, A., Cutolo, M., Mease, P., Gladman, D., Adebajo, A., Gomez-Reino, J., Wollenhaupt, J., Schett, G., Lespessailles, E., Hu, C., Stevens, R., Edwards, C., Birbara, C.
Published in Annals of the rheumatic diseases (01.06.2014)
Published in Annals of the rheumatic diseases (01.06.2014)
Get full text
Journal Article
SAT0299 Apremilast: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials in patients with Psoriatic Arthritis
Mease, P. J., Kavanaugh, A., Adebajo, A. O., Gomez-Reino, J. J., Wollenhaupt, J., Cutolo, M., Schett, G., Lespessailles, E., Shah, K., Hu, C., Stevens, R., Edwards, C. J., Birbara, C. A.
Published in Annals of the rheumatic diseases (01.06.2013)
Published in Annals of the rheumatic diseases (01.06.2013)
Get full text
Journal Article
Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial
Katz, N, Borenstein, D, Birbara, C, Bramson, C, Nemeth, M, Smith, M, Brown, M
Published in The journal of pain (01.04.2009)
Published in The journal of pain (01.04.2009)
Get full text
Journal Article
Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies
Birbara, C., Ruoff, G., Sheldon, E., Valenzuela, C., Rodgers, A., Petruschke, R. A., Chang, D. J., Tershakovec, A. M.
Published in Current medical research and opinion (01.01.2006)
Published in Current medical research and opinion (01.01.2006)
Get full text
Journal Article
Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study
Buckler, H, Fraser, W, Hosking, D, Ryan, W, Maricic, M.J, Singer, F, Davie, M, Fogelman, I, Birbara, C.A, Moses, A.M, Lyles, K, Selby, P, Richardson, P, Seaman, J, Zelenakas, K, Siris, E
Published in Bone (New York, N.Y.) (01.05.1999)
Published in Bone (New York, N.Y.) (01.05.1999)
Get full text
Journal Article
Conference Proceeding
Efficacy and safety of tanezumab in the treatment of chronic low back pain
Katz, Nathaniel, Borenstein, David G., Birbara, Charles, Bramson, Candace, Nemeth, Mary Anne, Smith, Mike D., Brown, Mark T.
Published in Pain (Amsterdam) (01.10.2011)
Published in Pain (Amsterdam) (01.10.2011)
Get full text
Journal Article
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2
van der Heijde, D., Kavanaugh, A., Gladman, D. D., Antoni, C., Krueger, G. G., Guzzo, C., Zhou, B., Dooley, L. T., de Vlam, K., Geusens, P., Birbara, C., Halter, D., Beutler, A.
Published in Arthritis and rheumatism (01.08.2007)
Published in Arthritis and rheumatism (01.08.2007)
Get full text
Journal Article